Tripothesis search
Search Tripotheses
Search Tripothesis titles, stable IDs, source terms, and source libraries across the current indexed Tripotheses.
try an example: UBTF, Body Mass Index, GWAS_Catalog_2023
Report collection
Top 25 Tripotheses
Ranking Strategy
Expand to see how the displayed Top 25 Tripotheses were prioritized from the multi-omics Tripothesis ranking pipeline.
Expand
Ranking Strategy
Expand to see how the displayed Top 25 Tripotheses were prioritized from the multi-omics Tripothesis ranking pipeline.
This strategy explains how the displayed Top 25 Tripotheses were prioritized from the multi-omics Tripothesis ranking pipeline.
1. Multi-omics overlap
Candidate Tripotheses are first formed from three distinct source gene-set libraries. The initial statistical rank favors stronger shared-gene evidence: higher conservative three-way -log10(p-value), then larger three-way overlap size, then higher three-way Jaccard similarity.
2. PubMed novelty
Each source term is mapped to a PubMed search entity. The novelty score rewards concepts that are individually findable in PubMed but sparsely co-mentioned as pairs or as the full three-term combination.
3. Final report selection
The final priority score blends statistical strength with PubMed novelty. The report queue then applies diversity filters so the top 25 are not dominated by repeated terms, library pairs, or highly similar shared-gene overlaps.
| Scoring field | How it is used |
|---|---|
| Statistical priority percentile | The statistical score rewards stronger three-way evidence: smaller conservative p-values, larger shared-gene overlap, and higher Jaccard similarity across the three input sets. The score is calculated as - log p-value + overlap size + 100 * Jaccard score, with additional credit for compact coverage, while being penalized for repeated sources, repeated terms, and common-gene dominance. This statistical score is then converted into a percentile from 0 to 100. |
| PubMed novelty score | A 0-100 score based on individual PubMed coverage plus scarcity of pairwise and three-way co-mentions. |
| Novelty-adjusted priority score | Balanced ranking score: 65% statistical priority percentile and 35% PubMed novelty by default. |
| Diversity filters | Limits repeated traits, regulators, perturbagens, source crossings, central PubMed terms, and near-duplicate shared-gene sets. |
| No. | Tripothesis title | Three terms | Report |
|---|---|---|---|
| 1 | Appendicular Lean Mass × UBTF ENCODE × GSE182680,GSE182683 5 V 11 DEXAMETHASONE HUMAN UP |
| View Report |
| 2 | Heel Bone Mineral Density × AMD3100 T-cell acute lymphoblastic leukemia (T-ALL) cells GSE60367 up × UBTF ENCODE |
| View Report |
| 3 | Systolic Blood Pressure × UBTF ENCODE × GSE147876,GSE147877 4 V 10 ENZALUTAMIDE HUMAN DN |
| View Report |
| 4 | Total Cholesterol Levels × AMD3100 T-cell acute lymphoblastic leukemia (T-ALL) cells GSE60367 up × UBTF ENCODE |
| View Report |
| 5 | Body Mass Index × SUZ12 CHEA × GSE113146 EGFR Inhibition 1 V 2 Mouse up |
| View Report |
| 6 | Appendicular Lean Mass × CHD1 ENCODE × GSE100148 EZH2 Inhibition 4 V 5 Human up |
| View Report |
| 7 | Liver Disease Biomarker × SMAD4 19686287 ChIP-ChIP HaCaT Human × RISPERIDONE |
| View Report |
| 8 | AMD3100 T-cell acute lymphoblastic leukemia (T-ALL) cells GSE60367 up × Basal metabolic rate 23105 raw × UBTF ENCODE |
| View Report |
| 9 | Basal metabolic rate 23105 raw × UBTF ENCODE × GSE182680,GSE182683 5 V 8 DEXAMETHASONE HUMAN UP |
| View Report |
| 10 | Heel Bone Mineral Density × CDX2 22108803 ChIP-Seq LS180 Human × GSE214596,GSE214598 1 V 2 ROSIGLITAZONE MOUSE DN |
| View Report |
| 11 | Ankle spacing width 3143 raw × FUS 26573619 Chip-Seq HEK293 Human × GSE236454,GSE236456 0 V 1 ANGIOTENSIN II MOUSE DN |
| View Report |
| 12 | Appendicular Lean Mass × PGR KO MOUSE GSE39920 CREEDSID GENE 3080 UP × Pgr KO mouse GSE39920 sample 3080 |
| View Report |
| 13 | AMD3100 T-cell acute lymphoblastic leukemia (T-ALL) cells GSE60367 up × Basal metabolic rate 23105 raw × GATA1 CHEA |
| View Report |
| 14 | Basal metabolic rate 23105 raw × RUNX1 CHEA × GSE190534,GSE190536 0 V 3 CYCLOPHOSPHAMIDE MOUSE DN |
| View Report |
| 15 | Body fat percentage 23099 raw × GATA1 CHEA × GSE182680,GSE182683 5 V 8 DEXAMETHASONE HUMAN UP |
| View Report |
| 16 | Body Mass Index × SOX2 DEFICIENCY HUMAN GSE42937 CREEDSID GENE 347 UP × SOX2 Deficiency human GSE42937 sample 347 |
| View Report |
| 17 | Body Mass Index × CDX2 22108803 ChIP-Seq LS180 Human × GSE147876,GSE147877 4 V 11 ENZALUTAMIDE HUMAN DN |
| View Report |
| 18 | Body Mass Index × CDX2 22108803 ChIP-Seq LS180 Human × GSE198826,GSE198911 1 V 2 DEXAMETHASONE MOUSE UP |
| View Report |
| 19 | Both eyes present 5182 1 × SUZ12 CHEA × GSE114492 GSE153671 KMT2D Inhibition 2 V 11 Human up |
| View Report |
| 20 | Systolic Blood Pressure × CEBPD 23245923 ChIP-Seq MEFs Mouse × A549 BISINDOLYLMALEIMIDE IX 10NM 24H DN |
| View Report |
| 21 | Systolic Blood Pressure × NUCKS1 24931609 ChIP-Seq HEPATOCYTES Mouse × GSE107288 DCPS Inhibition Granulocyte Monocyte Progenitor Cell RNA Messenger 4 V 2 Mouse up |
| View Report |
| 22 | Blood Protein Levels × KLF15 DEFICIENCY MOUSE GSE7137 CREEDSID GENE 675 UP × Mouse liver 10 months vs 22 months GSE3150 aging:326 |
| View Report |
| 23 | Blood Protein Levels × SOX3 KO MOUSE GSE53760 CREEDSID GENE 1668 UP × Sox3 KO mouse GSE53760 sample 1668 |
| View Report |
| 24 | Body fat percentage 23099 raw × SOX3 KO MOUSE GSE53760 CREEDSID GENE 1668 UP × Sox3 KO mouse GSE53760 sample 1668 |
| View Report |
| 25 | Blood Protein Levels × KLF15 DEFICIENCY MOUSE GSE7137 CREEDSID GENE 675 UP × Ppargc1b Hypomorphic Mutation mouse GSE6210 sample 1191 |
| View Report |
